23andMe Holding EBIT

23andMe Holding (ME) currently reports a EBIT of $-170M as of June 2025. That compares with $-85M in the prior-year period — down 93.5% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore 23andMe Holding's EBIT history and peer comparisons.

23andMe Holding's EBIT decreased from $-85M to $-170M — a 93.5% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

23andMe Holding's EBIT of $-170M is lower than the Healthcare sector average of $22B. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

23andMe Holding reported $-170M in EBIT as of June 2025. That compares with $-85M in the prior-year period — down 93.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-170M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for 23andMe Holding, and consider following ME for alerts when major investors trade the stock.